Table 2.
Assessing clinical severity of COVID-19 by univariate and multivariate statistical analysis.
| Outcome: Severity | Univariate | Multivariate Ordinal Logistic Regression |
||||
|---|---|---|---|---|---|---|
| Asymptomatic-Mild (%) | Moderate (%) | Severe-Critical (%) | Sig. | Sig. | aOR with 95% CI | |
| Sex (Male) | 94 (49.5) | 210 (56.3) | 144 (73.1) | <0.001 (C) | <0.001 | 1.98 (1.47–2.66) |
| Age (median, IQR) | 52 (32) | 65 (18) | 72 (16) | <0.001 (Κ–W) | <0.001 | 1.052 (1.040–1.064) |
| Atrial Fibrillation | 51 (26.8) | 93 (24.9) | 83 (42.6) | <0.001 (C) | 0.373 | 0.85 (0.60–1.21) |
| Chronic respiratory disease | 15 (7.9) | 38 (10.2) | 41 (20.8) | <0.001 (C) | 0.098 | 1.45 (0.93–2.26) |
| Coronary disease | 20 (10.5) | 69 (18.5) | 53 (26.9) | <0.001 (C) | 0.634 | 1.10 (0.73–1.67) |
| Diabetes mellitus Type II | 29 (15.3) | 79 (21.2) | 48 (24.4) | 0.078 (C) | 0.331 | 0.83 (0.58–1.20) |
| Neoplasia | 20 (10.5) | 35 (9.4) | 30 (15.2) | 0.108 (C) | 0.173 | 0.73 (0.47–1.15) |
| Hypertension | 69 (36.3) | 204 (54.7) | 147 (74.6) | <0.001 (C) | 0.104 | 1.34 (0.94–1.91) |
| β-Thalassemia heterozygosity | 15 (7.9) | 66 (17.7) | 56 (28.4) | <0.001 (C) | <0.001 | 2.59 (1.78–3.77) |
C, Chi-square test; K–W, Kruskal–Wallis Test.